Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolfs

Showing results (591-600 of 632) with videos related to

Pageof 64
Sort By:
Diagnostics (Basel, Switzerland)|September 9, 2023
Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF StudyFilipa Curado, Sabine Rösner, Susanne Zielke, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 31, 2015
Cervical artery dissection in young adults in the stroke in young Fabry patients (sifap1) studyBettina von Sarnowski, Ulf Schminke, Ulrike Grittner, et al.
Annals of Neurology|December 11, 2007
Long-term course and mutational spectrum of spatacsin-linked spastic paraplegiaUte Hehr, Peter Bauer, Beate Winner, et al.
Stroke|November 15, 2012
Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients studyBettina von Sarnowski, Jukka Putaala, Ulrike Grittner, et al.
Genome Research|February 27, 2007
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiaeYanhui Hu, Andreas Rolfs, Bhupinder Bhullar, et al.
Journal of Medical Genetics|October 26, 2019
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsyYoon-Myung Kim, Mi-Sun Yum, Sun Hee Heo, et al.
Stroke|January 12, 2013
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients studyArndt Rolfs, Franz Fazekas, Ulrike Grittner, et al.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
JIMD Reports|February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortageGabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.
Annals of Neurology|April 12, 2019
A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonismAna Westenberger, Charles Jourdan Reyes, Gerard Saranza, et al.
Pageof 64

Showing results (591-600 of 632) with videos related to

Sort By:
Pageof 64
Diagnostics (Basel, Switzerland)|September 9, 2023
Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF StudyFilipa Curado, Sabine Rösner, Susanne Zielke, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 31, 2015
Cervical artery dissection in young adults in the stroke in young Fabry patients (sifap1) studyBettina von Sarnowski, Ulf Schminke, Ulrike Grittner, et al.
Annals of Neurology|December 11, 2007
Long-term course and mutational spectrum of spatacsin-linked spastic paraplegiaUte Hehr, Peter Bauer, Beate Winner, et al.
Stroke|November 15, 2012
Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients studyBettina von Sarnowski, Jukka Putaala, Ulrike Grittner, et al.
Genome Research|February 27, 2007
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiaeYanhui Hu, Andreas Rolfs, Bhupinder Bhullar, et al.
Journal of Medical Genetics|October 26, 2019
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsyYoon-Myung Kim, Mi-Sun Yum, Sun Hee Heo, et al.
Stroke|January 12, 2013
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients studyArndt Rolfs, Franz Fazekas, Ulrike Grittner, et al.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
JIMD Reports|February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortageGabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.
Annals of Neurology|April 12, 2019
A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonismAna Westenberger, Charles Jourdan Reyes, Gerard Saranza, et al.
Pageof 64